Varicella-zoster immunoglobulin treatment in pregnant women in Denmark from 2005 to 2015: descriptive epidemiology and follow-up
- PMID: 27535469
- PMCID: PMC9150214
- DOI: 10.1017/S0950268816001485
Varicella-zoster immunoglobulin treatment in pregnant women in Denmark from 2005 to 2015: descriptive epidemiology and follow-up
Abstract
Primary infection with varicella-zoster virus in pregnancy poses a risk of severe infection and embryopathies. Upon exposure, seronegative women are candidates for varicella-zoster immunoglobulin (VZIG). The aim of this paper was to describe risk factors for VZIG treatment including sources of varicella exposure and to study how many women developed clinical infection and received postpartum vaccination. We identified all pregnant women who received VZIG from December 2005 to March 2015. Additional information was obtained from Danish registers and a follow-up questionnaire. A total of 104 women were included and 88 completed the questionnaire. Significantly more women had 'other country of origin' than Denmark. They were more often second para (57%) and had most commonly been exposed to varicella by their own child (58%). Five women developed clinical varicella infection, and only 26·5% were vaccinated after delivery. The study concludes that few women developed infection after VZIG and none developed pneumonia. General practitioners should be particularly aware of obtaining varicella anamnesis in parous women from non-temperate countries in order to perform selective vaccination prior to pregnancy. In case of varicella exposure during pregnancy in a seronegative woman, postpartum vaccination is crucial.
Keywords: Chickenpox; epidemiology; infectious disease epidemiology; vaccination (immunization); varicella zoster.
Figures
Similar articles
-
Management of varicella infection (chickenpox) in pregnancy.J Obstet Gynaecol Can. 2012 Mar;34(3):287-292. doi: 10.1016/S1701-2163(16)35190-8. J Obstet Gynaecol Can. 2012. PMID: 22385673 Review.
-
Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women.J Clin Pharmacol. 2002 Mar;42(3):267-74. doi: 10.1177/00912700222011283. J Clin Pharmacol. 2002. PMID: 11865962 Clinical Trial.
-
VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.J Infect. 2007 Jul;55(1):64-7. doi: 10.1016/j.jinf.2007.02.003. Epub 2007 Apr 5. J Infect. 2007. PMID: 17418420
-
[Primary varicella-zoster virus infection--current knowledge, diagnostic and therapeutic approaches].Med Pregl. 2000 May-Jun;53(5-6):272-6. Med Pregl. 2000. PMID: 11089369 Review. Croatian.
-
Varicella zoster immunoglobulin after postnatal exposure to varicella: survey of experts.Pediatr Infect Dis J. 1987 May;6(5):466-70. doi: 10.1097/00006454-198705000-00011. Pediatr Infect Dis J. 1987. PMID: 3037474
Cited by
-
Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature.Front Immunol. 2018 Jul 16;9:1632. doi: 10.3389/fimmu.2018.01632. eCollection 2018. Front Immunol. 2018. PMID: 30079064 Free PMC article. Review.
-
Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program.PLoS One. 2019 Jul 3;14(7):e0217749. doi: 10.1371/journal.pone.0217749. eCollection 2019. PLoS One. 2019. PMID: 31269033 Free PMC article. Clinical Trial.
-
Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):449-453. doi: 10.1093/jpids/piz070. J Pediatric Infect Dis Soc. 2020. PMID: 31774916 Free PMC article.
-
Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.PLoS One. 2019 Aug 13;14(8):e0221084. doi: 10.1371/journal.pone.0221084. eCollection 2019. PLoS One. 2019. PMID: 31408478 Free PMC article. Clinical Trial.
-
Epidemiology, management and outcome of varicella in pregnancy: a 20-year experience at the Tuscany Reference Centre for Infectious Diseases in Pregnancy.Infection. 2018 Oct;46(5):693-699. doi: 10.1007/s15010-018-1150-4. Epub 2018 May 15. Infection. 2018. PMID: 29766472
References
-
- Heininger U, Seward JF. Varicella. Lancet 2006; 368: 1365–1376. - PubMed
-
- Statens Serum Institut. Chicken pox (http://www.ssi.dk/Service/Sygdomsleksikon/S/Skoldkopper.aspx). Accessed 7 January 2015.
-
- Public Health England. Varicella: the green book, chapter 34, 2012 (https://www.gov.uk/government/uploads/system/uploads/attachment_data/fil...).
-
- Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122: e744–751. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources